Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "specialty"

641 News Found

Dr Jitendra Singh commends SCTIMST doctors for treating  17,000 patients under AB-PMJAY
Hospitals | May 18, 2026

Dr Jitendra Singh commends SCTIMST doctors for treating 17,000 patients under AB-PMJAY

At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem


Senores Pharma doubles profit as sales surge 62%
News | May 15, 2026

Senores Pharma doubles profit as sales surge 62%

Global specialty pipeline accelerates growth


Senores Pharma reports 62% rise in FY26 total income to Rs. 664 crore
News | May 15, 2026

Senores Pharma reports 62% rise in FY26 total income to Rs. 664 crore

The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives


OneSource records Rs. 4,282 million revenue in Q4 FY26
News | May 15, 2026

OneSource records Rs. 4,282 million revenue in Q4 FY26

Backed by Semaglutide launches, the company reported 47% quarter-on-quarter revenue growth in Q4 FY26, with EBITDA expanding more than fivefold


Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push
News | May 14, 2026

Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push

Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support


AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management
Healthcare | May 13, 2026

AstraZeneca launches K+ Connect initiative to strengthen hyperkalemia management

Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure


CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge
News | May 12, 2026

CORONA Remedies posts robust FY26 with 17.3% revenue growth, 33.4% PAT surge

The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market


Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
Healthcare | May 08, 2026

Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore

Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands


Safic-Alcan expands in India with majority stake in SA Ingredients
News | May 07, 2026

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint


Medanta appoints Dr Shalini Tyagi as Director, Paediatric Care at Noida unit
Hospitals | May 05, 2026

Medanta appoints Dr Shalini Tyagi as Director, Paediatric Care at Noida unit

Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.